Lisdexamfetamine Dimesylate
Overview
Lisdexamfetamine Dimesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201178).
API suppliers (6)
Suppliers of Lisdexamfetamine Dimesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
2 of 6 hold a GMP certificate on record in the EU or UK registers
- VERANOVA LPUnited Kingdom1 active DMF
- SPECGX LLCUnited States1 active DMF
- CHATTEM CHEMICALS INCUnited States1 active DMF
- Alkem Laboratories LimitedIndia1 active DMF GMP on record
- Granules India LimitedIndia1 active DMF GMP on record
- ARENE LIFE SCIENCES PRIVATE LIMITED1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (161 approved US products), the latest listed US patent on Lisdexamfetamine Dimesylate expires 30 Aug 2040. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid
- Canonical SMILES
- C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O
- InChIKey
- CETWSOHVEGTIBR-FORAGAHYSA-N
Do you supply Lisdexamfetamine Dimesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.